Carbapenem resistance in a clinical isolate of Citrobacter freundii

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 11, 1997, Pages 2352-2354

  Mainardi, Jean Luc ^a,b   Mugnier, Pierre ^b   Coutrot, Anne ^a   Buu HOÏ, Annie ^c   Collatz, Ekkehard ^b   Gutmann, Laurent ^b,c  

^a SAINT JOSEPH HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL BROUSSAIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CARBAPENEM; CEFALORIDINE; CEPHALOSPORINASE; IMIPENEM; LATAMOXEF; MEROPENEM; OUTER MEMBRANE PROTEIN; PORIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; CITROBACTER FREUNDII; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; MEMBRANE PERMEABILITY; MICHAELIS CONSTANT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REVERTANT;

EID: 0030699988     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.11.2352     Document Type: Article

References (29)

1. Aoyama H., K. Fujimaki, K. Sato, T. Fujii, M. Inoue, K. Hirai, and S. Mitsuhashi. 1988. Clinical isolate of Citrobacter freundii highly resistant to new quinolones. Antimicrob. Agents Chemother. 32:922-924.
2. Augustinsson, K. B. 1960. The enzymes, vol. 4, p. 251. In P. D Boyer, H. Lardy, and K. Myrback (ed.). Academic Press, Inc., New York N.Y.
3. Bradford, P. A., C. Urban, N. Mariano, S. J. Projan, J. J. Rahal and K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41.563-569.
4. Bush, K., S. K. Tanaka, D. P. Bonner, and R. B. Sykes. 1985. Resistance caused by decreased penetration of β-lactam antibiotics into Enterobacter cloacae. Antimicrob. Agents Chemother. 27:555-560.
5. Chow, J. W., and D. M. Shlaes. 1991. Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes. J. Antimicrob. Chemother. 28:499-504.
6. De Champs, C., C. Henquell, D. Guelon, D. Sirot, N. Gazuy, and J. Sirot. 1993. Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes. J. Clin. Microbiol. 31:123-127.
7. Ehrhard, A. F. C., C. C. Sanders, K. S. Thomson, C. Watanakunakorn, and I. Trujillano-Martin. 1993. Emergence of resistance to imipenem in Enterobacter isolates masquerading as Klebsiella pneumoniae during therapy with imipenem/cilastatin. Clin. Infect. Dis. 17:120-122.
8. Gutmann, L., R. Williamson, N. Moreau, M. D. Kitzis, E. Collatz, J. F. Acar, and F. W. Goldstein. 1985. Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter and Serratia. J. Infect. Dis. 151:501-507.
9. Honoré N., M. H. Nicolas, and S. T. Cole. 1986. Regulation of enterobacterial cephalosporinase production: the role of membrane bound sensory transducer. Mol. Microbiol. 3:1121-1130.
10. Hopkins, J. M., and K. J. Towner. 1990. Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenes. J. Antimicrob. Chemother. 25:49-55.
11. Lee E. H., M. H. Nicolas, M. D. Kitzis, G. Pialoux, E. Collatz, and L. Gutmann 1991. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem. Antimicrob Agents Chemother. 35:1093-1098.
12. Livermore, D. M. 1992. Interplay of impermeability and chromosomal β-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36:2046-2048.
13. Maniatis T., E. F. Fritsh, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
14. Matthew, M., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of β-lactamase. J. Gen. Microbiol. 88:169-178.
15. Mehtar S., A. Tsakris, and T. L Pitt. 1991. Imipenem resistance in Proteus mirabilis. J. Antimicrob. Chemother. 28:612-615.
16. Nass, T., L. Vandel, W. Sougakoff, D. M. Livermore, and P. Nordmann. 1994. Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A β-lactamase, Sme-1, from Serratia marcescens S6. Antimicrob. Agents Chemother. 38:1262-1270.
17. Nass, T., D. Livermore, and P. Nordmann. 1995. Characterization of an LysR family protein, SmeR from Serratia marcescens S6, its effect on expression of the carbapenem-hydrolyzing β-lactamase Sme-1, and comparison of this regulator with other β-lactamase regulators. Antimicrob. Agents Chemother. 39:629-637.
18. Nélet, F., L. Gutmann, M. D. Kitzis, and J. F. Acar. 1989. Tigemonam activity against clinical isolates of Enterobacteriaceae and Enterobacteriaceae with known mechanisms of resistance to β-lactam antibiotics. J. Antimicrob. Chemother. 24:173-181.
19. Neuwirth, C., E. Siéblor, J. M. Duez, A. Pechinot, and A. Kazmierczak. 1995. Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins. J. Antimicrob. Chemother. 36:335-342.
20. Nordmann, P., S. Mariotte, T. Naas, R. Labia, and M. H. Nicolas. 1993. Biochemical properties of a carbapenem-hydrolyzing β-lactamase from Enterobacter cloacae and cloning of its gene into Escherichia coli. Antimicrob. Agents Chemother. 37:939-946.
21. Osano, E., Y. Arakawa, R. Wacharotayankun, M. Ohta, T. Horii, H. Ito, F. Yoshimura and N. Kato. 1994. Molecular characterization of an enterobacterial metallo-β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 38:71-78.
22. Raimondi, A., A. Traverso, and H. Nikaido. 1991. Imipenem-and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgerii lack porins. Antimicrob. Agents Chemother. 35:1174-1180.
23. Ramakrishnan, G., K. Ikenaka, and M. Inouye. 1985. Uncoupling of osmoregulation of the Escherichia coli K-12 ompF gene from ompB-dependent transcription. J. Bacteriol. 163:82-87.
24. Rasmussen, B. A., K. Bush, D. Keeney, Y. Yang, R. Hare, C. O'Gara, and A. A. Medeiros. 1996. Characterization of IMI-1 β-lactamase, a class A carabapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob. Agents Chemother. 40:2080-2086.
25. Thompson, K. S., C. C. Sanders, and H. Chmel. 1993. Imnipenem resistance in Enterobacter aerogenes. Eur. J. Clin. Microbiol. Infect. Dis. 12:610-613.
26. Tzouvelekis, L. S., E. Tzelepi, A. F. Mentis, A. C. Vatapoulos, and A. Tsakaris. 1992. Imipenem resistance in Enterobacter aerogenes is associated with derepression of chromosomal cephalosporamines and impaired permeability. FEMS Microbiol. Lett. 95:195-200.
27. Yang , Y., P. Wu, and D. M. Livermore. 1990. Biochemical characterization of a β-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates. Antimicrob. Agents Chemother. 34:755-758.
28. Zhou, X. Y., M. D. Kitzis, J. F. Acar, and L. Gutmann. 1993. Activity of the β-lactamase inhibitor BRL 42715 against cephalosporinases produced by Enterobacteriaceae. J. Antimicrob. Chemother. 31:473-480.
29. Zhou, X. Y., M. D. Kitzis, and L. Gutman. 1993. Role of cephalosporinase in carbapenem resistance of clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 37:1387-1389.